Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.

Evoke Pharma (EVOK) underscores its commitment to patients and healthcare providers managing gastroparesis in light of FDA’s recent update ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only ...

The definition of successful GPOEM varied across studies. The most common definitions were a one-point reduction in gastroparesis cardinal symptom index (GCSI), a one-point reduction in GCSI with a 25 ...